CAMBRIDGE, Mass., Aug. 25, 2022 -- Aktis Oncology, a biotechnology company discovering and developing novel classes of targeted alpha radiopharmaceuticals to treat a broad range of solid tumors, today announced...
Art Pappas will be speaking on two panels, Starting Up Biotechs in the New Normal World and Success in the States: A Guide for Foreign Companies to the Largest Venture Capital Pool in the World, at the Bio 2011 conference in Washington, D.C.
News | 06. 29. 2011
